Medical Science Liaison (Medtech)

TL;DR

Medical Science Liaison (Medtech): Providing clinical and product education to HCPs to drive adoption of molecular breast cancer tests with an accent on genomic expertise and KOL relationship management. Focus on stimulating investigator-initiated studies, distilling complex scientific data, and supporting the clinical utility of diagnostic assays.

Location: Remote (US). Requires ability to travel at least 60% within the central United States.

Salary: $160,000 — $196,000 USD

Company

hirify.global is a global diagnostics company leveraging genomic data and AI to transform cancer care and empower clinicians with high-value insights.

What you will do

• Develop and maintain relationships with academic and community physicians to promote the Prosigna Breast Cancer test.
• Identify KOLs and facilitate investigator-initiated studies from inception through article publication.
• Deliver tailored scientific presentations to HCPs and provide clinical updates to internal sales and marketing teams.
• Collaborate with Medical Affairs to collect real-world evidence and implement product improvement strategies.
• Analyze literature to create educational materials for external HCPs and internal stakeholders.
• Support the managed care team with scientific data for insurance coverage applications.

Requirements

• Terminal scientific or clinical degree (Ph.D., M.D., Pharm.D., or D.O.).
• At least 5 years of clinical or industry experience, preferably with an oncology focus.
• Must be based in the US.
• Deep understanding of the genetic basis for disease, modern genomic techniques, and the peer-review publication process.
• Strong interpersonal and communication skills to convey complex scientific results to diverse audiences.
• Ability to travel 60%+ to provide education to HCPs in the central US region.

Nice to have

• Prior experience as an MSL introducing and supporting novel diagnostic assays.
• Familiarity with statistical methodologies.

Culture & Benefits

• Purpose-driven environment focused on transforming cancer care for patients globally.
• Comprehensive compensation including base pay, discretionary bonuses, and restricted stock units (RSUs).
• Inclusive workforce, recognized as a 2024 Certified™ Great Place to Work® in the US and Israel.
• Culture rooted in bold ideas, empathy, integrity, and collaboration.